The S&P healthcare index gained 2.7
percent, while the Nasdaq Biotech Index jumped 6 percent. Shares of Pfizer rose
5 percent to USD 32.93 and gave the biggest boost to the S&P 500, while
Allergan was up 3.5 percent at USD 244.74.
"I guess the feeling is Pfizer will now
look for a new target," said Stephen Massocca, chief investment officer,
Wedbush Equity Management LLC in San Francisco. But, he said, "the rally
in healthcare is a little counter-intuitive, given the political climate seems
to be negative for big pharma right now."
The Dow Jones
industrial average was up 112.73 points, or 0.64 percent, to 17,716.05, the
S&P 500 had gained 21.49 points, or 1.05 percent, to 2,066.66 and the
Nasdaq Composite had added 76.78 points, or 1.59 percent, to 4,920.72.
For Free Trial & Join Services For All Segment Click Here
No comments:
Post a Comment